Luteolin Isolated from


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
23 May 2023
Historique:
received: 06 05 2023
revised: 17 05 2023
accepted: 18 05 2023
medline: 12 6 2023
pubmed: 10 6 2023
entrez: 10 6 2023
Statut: epublish

Résumé

The COVID-19 pandemic, caused by SARS-CoV-2, addressed the lack of specific antiviral drugs against coronaviruses. In this study, bioguided fractionation performed on both ethyl acetate and aqueous sub-extracts of

Identifiants

pubmed: 37298740
pii: molecules28114263
doi: 10.3390/molecules28114263
pmc: PMC10254368
pii:
doi:

Substances chimiques

Luteolin KUX1ZNC9J2
Antiviral Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : PHC Utique 2020 Program
ID : Campus France code: 44197ZG & CMCU code: 20G0822

Références

J Agric Food Chem. 2015 Sep 9;63(35):7693-9
pubmed: 25843231
J Med Virol. 2022 Apr;94(4):1373-1390
pubmed: 34897729
Mol Pharm. 2016 Feb 1;13(2):568-77
pubmed: 26656210
Phytochemistry. 2007 Nov-Dec;68(22-24):2973-85
pubmed: 17950388
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
J Virol. 2004 Oct;78(20):11334-9
pubmed: 15452254
PLoS One. 2012;7(3):e32857
pubmed: 22412934
J Pharm Pharmacol. 2017 Aug;69(8):1041-1055
pubmed: 28444868
Virus Res. 2016 Jul 15;220:112-6
pubmed: 27126774
N Engl J Med. 2022 Apr 14;386(15):1397-1408
pubmed: 35172054
Proc Soc Exp Biol Med. 1966 Jan;121(1):190-3
pubmed: 4285768
Virol J. 2020 Nov 25;17(1):187
pubmed: 33239033
PLoS One. 2011;6(11):e27915
pubmed: 22140483
J Virol. 2019 May 1;93(10):
pubmed: 30842319
Case Rep Infect Dis. 2018 Apr 15;2018:6796839
pubmed: 29850307
J Med Microbiol. 2020 Jun;69(6):864-873
pubmed: 32469301
Nat Struct Mol Biol. 2021 Sep;28(9):740-746
pubmed: 34381216
Cancer Discov. 2021 Jun;11(6):1336-1344
pubmed: 33846172
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
J Ethnopharmacol. 2018 Oct 28;225:342-358
pubmed: 29801717
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9864-9
pubmed: 27528677
Sci Rep. 2022 Jun 22;12(1):10571
pubmed: 35732785
New Phytol. 2015 Apr;206(2):557-70
pubmed: 25495078
Plant Cell Physiol. 2016 Jan;57(1):e10
pubmed: 26519912
Virus Genes. 2012 Dec;45(3):433-9
pubmed: 22926811
CNS Neurol Disord Drug Targets. 2019;18(5):352-365
pubmed: 30892166
Front Pharmacol. 2022 Aug 19;13:926507
pubmed: 36059994
Database (Oxford). 2022 Mar 19;2022:
pubmed: 35305011
Viruses. 2022 Jan 27;14(2):
pubmed: 35215848
EMBO J. 2021 Aug 16;40(16):e107821
pubmed: 34159616
Eur Rev Med Pharmacol Sci. 2021 Jun;25(11):4156-4162
pubmed: 34156697
Science. 2016 Jan 1;351(6268):81-4
pubmed: 26678874
J Virol. 2010 Dec;84(24):12658-64
pubmed: 20926566
Viruses. 2014 Jul 17;6(7):2778-95
pubmed: 25036464
Biosaf Health. 2021 Apr;3(2):87-91
pubmed: 33585808
Virus Res. 2020 Jul 15;284:197989
pubmed: 32360300
Nat Prod Res. 2013;27(2):155-63
pubmed: 22360833
Phytochemistry. 2008 Mar;69(5):1084-110
pubmed: 18243254
Environ Sci Pollut Res Int. 2022 Feb;29(8):12336-12346
pubmed: 34562220
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
J Nat Med. 2019 Jun;73(3):487-496
pubmed: 30758716
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0158121
pubmed: 34807755
J Virol. 2011 Jan;85(2):873-82
pubmed: 21068237
Curr Cancer Drug Targets. 2008 Nov;8(7):634-46
pubmed: 18991571
J Ethnopharmacol. 2013 Oct 7;149(3):648-55
pubmed: 23920249
Front Pharmacol. 2021 Jan 08;11:586548
pubmed: 33488385
Front Microbiol. 2022 Sep 29;13:1031204
pubmed: 36246297
J Ethnopharmacol. 2012 Dec 18;144(3):545-54
pubmed: 23026306
PLoS Pathog. 2021 Feb 17;17(2):e1009225
pubmed: 33596266
Lancet Infect Dis. 2020 Sep;20(9):e238-e244
pubmed: 32628905
Mini Rev Med Chem. 2009 Jan;9(1):31-59
pubmed: 19149659
Bull Natl Res Cent. 2021;45(1):27
pubmed: 33495684
Lancet. 2022 May 21;399(10339):1941-1953
pubmed: 35512728
J Nat Med. 2015 Jul;69(3):421-6
pubmed: 25794817
Methods Mol Biol. 2012;910:87-124
pubmed: 22821594
Biomedicines. 2021 Jun 18;9(6):
pubmed: 34207313

Auteurs

Asma Hakem (A)

Joint Research Unit 1158, BioEcoAgro, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d'Opale, ICV-Institut Charles Viollette, 59650 Villeneuve-d'Ascq, France.
Laboratory of Aromatic and Medicinal Plants, Biotechnology Centre of Borj-Cedria (CBBC), Hammam-Lif 2050, Tunisia.

Lowiese Desmarets (L)

Center for Infection and Immunity of Lille (CIIL), Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, 59000 Lille, France.

Ramla Sahli (R)

Joint Research Unit 1158, BioEcoAgro, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d'Opale, ICV-Institut Charles Viollette, 59650 Villeneuve-d'Ascq, France.
Laboratory of Aromatic and Medicinal Plants, Biotechnology Centre of Borj-Cedria (CBBC), Hammam-Lif 2050, Tunisia.

Rawen Ben Malek (RB)

Joint Research Unit 1158, BioEcoAgro, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d'Opale, ICV-Institut Charles Viollette, 59650 Villeneuve-d'Ascq, France.

Charline Camuzet (C)

Center for Infection and Immunity of Lille (CIIL), Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, 59000 Lille, France.

Nathan François (N)

Center for Infection and Immunity of Lille (CIIL), Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, 59000 Lille, France.

Gabriel Lefèvre (G)

Joint Research Unit 1158, BioEcoAgro, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d'Opale, ICV-Institut Charles Viollette, 59650 Villeneuve-d'Ascq, France.

Jennifer Samaillie (J)

Joint Research Unit 1158, BioEcoAgro, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d'Opale, ICV-Institut Charles Viollette, 59650 Villeneuve-d'Ascq, France.

Sophie Moureu (S)

Joint Research Unit 1158, BioEcoAgro, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d'Opale, ICV-Institut Charles Viollette, 59650 Villeneuve-d'Ascq, France.

Sevser Sahpaz (S)

Joint Research Unit 1158, BioEcoAgro, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d'Opale, ICV-Institut Charles Viollette, 59650 Villeneuve-d'Ascq, France.

Sandrine Belouzard (S)

Center for Infection and Immunity of Lille (CIIL), Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, 59000 Lille, France.

Riadh Ksouri (R)

Laboratory of Aromatic and Medicinal Plants, Biotechnology Centre of Borj-Cedria (CBBC), Hammam-Lif 2050, Tunisia.

Karin Séron (K)

Center for Infection and Immunity of Lille (CIIL), Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017, 59000 Lille, France.

Céline Rivière (C)

Joint Research Unit 1158, BioEcoAgro, Univ. Lille, INRAE, Univ. Liège, UPJV, JUNIA, Univ. Artois, Univ. Littoral Côte d'Opale, ICV-Institut Charles Viollette, 59650 Villeneuve-d'Ascq, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH